NKGen Biotech, Inc.
NKGNDelisted Jul 17, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001845459
NKGen Biotech, Inc. was delisted on Jul 17, 2025; its insiders filed their last Form 4 on Jun 2, 2025; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in NKGen Biotech, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +3 vs. Q2 2024
- Shares held
- 3.75M
- +353.7K (+10.4%) vs. Q2 2024
- Total value
- $1.23M
- −$2.99M (−70.9%) vs. Q2 2024
- New holders
- 4
- 7 more added
- Sold out
- 1
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $165.4K |
| Q1 2026 | 1 | $192.9K |
| Q4 2025 | 1 | $137.8K |
| Q3 2025 | 1 | $303.2K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 3 | $160.8K |
| Q4 2024 | 25 | $5.07M |
| Q3 2024 | 19 | $1.23M |
| Q2 2024 | 17 | $4.24M |
| Q1 2024 | 13 | $5.66M |
| Q4 2023 | 9 | $13.7M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding NKGen Biotech, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meteora Capital, LLC | 884,745 | $334.4K | 0.09% | −283,245−24.3% | Reduced |
| Polar Asset Management Partners Inc. | 1,181,872 | $257.7K | 0.01% | +101,872+9.4% | Added |
| University of Chicago | 550,000 | $207.9K | 0.18% | 00.0% | Unchanged |
| Diametric Capital, LP | 518,134 | $195.9K | 0.10% | +184,800+55.4% | Added |
| Vanguard Group Inc | 227,804 | $86.1K | 0.00% | +174,000+323.4% | Added |
| Geode Capital Management, LLC | 112,714 | $42.6K | 0.00% | +44,275+64.7% | Added |
| Citadel Advisors LLC | 95,438 | $36.1K | 0.00% | +95,438 | New |
| Sequoia Financial Advisors, LLC | 69,000 | $26.1K | 0.00% | +50,500+273.0% | Added |
| Northern Trust Corp | 29,082 | $11.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 24,475 | $9.25K | 0.00% | +24,475 | New |
| UBS Group AG | 14,646 | $5.54K | 0.00% | −29,171−66.6% | Reduced |
| Tower Research Capital LLC (TRC) | 11,735 | $4.44K | 0.00% | +8,850+306.8% | Added |
| State Street Corp | 11,200 | $4.23K | 0.00% | 00.0% | Unchanged |
| Towneley Capital Management, Inc | 10,000 | $3.78K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,318 | $3.00K | 0.00% | −1,071−9.4% | Reduced |
| BlackRock, Inc. | 1,854 | $701 | 0.00% | +1,854 | New |
| Federation des caisses Desjardins du Quebec | 500 | $189 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 106 | $40 | 0.00% | +56+112.0% | Added |
| JPMorgan Chase & Co | 31 | $12 | 0.00% | +31 | New |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,917−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |